Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema - Reply

被引：10
|
作者：
Beck, TR
Baird, LG
机构：
[1] Dyax Corp, Business & Prod Dev, Cambridge, MA 02139 USA
[2] Dyax Corp, Dev, Cambridge, MA 02139 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.10.044
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [41] Tissue kallikrein gene polymorphism and angioedema in patients with hereditary C1 inhibitor deficiency
    Frémeaux-Bacchi, V
    Guinnepain, MT
    Weiss, L
    Blouin, J
    Laurent, J
    Fridman, WH
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 164 - 164
  • [42] Immunogenicity profile of lanadelumab, a fully human monoclonal antibody plasma kallikrein inhibitor, for the prevention of angioedema attacks in patients with hereditary angioedema
    Maurer, M.
    Zuraw, B. L.
    Sexton, D. J.
    Theobald, V
    ALLERGY, 2017, 72 : 99 - 100
  • [43] Genetic deficiency of C1 inhibitor in patient with hereditary angioedema
    Fremeaux-Bacchi, V.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2008, 48 (04): : 344 - 346
  • [44] BCX-4161, a Small Molecule and Orally Bioavailable Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema
    Bantia, Shanta
    Zhang, Jianwen
    Wilson, Ramanda
    Parker, Cynthia D.
    Kellogg, Debra
    Kotian, Pravin
    Babu, Y. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB211 - AB211
  • [45] Preclinical Characterization of BCX7353, an Oral Plasma Kallikrein Inhibitor, for the Treatment of Hereditary Angioedema (HAE)
    Chen, Xilin
    Kotian, Pravin
    Wilson, Ramanda
    Parker, Cynthia D.
    Babu, Y. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB230 - AB230
  • [46] Potency, Selectivity, and Exposure Evaluation of ATN-249, a New Oral Kallikrein Inhibitor for Hereditary Angioedema
    Kalfus, Ira
    McDonald, Andrew
    Qian, Shawn
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB378 - AB378
  • [47] Hereditary angioedema and normal C1-inhibitor activity in women - Reply
    Bork, K
    Barnstedt, SE
    Koch, P
    Traupe, H
    LANCET, 2000, 356 (9239): : 1440 - 1441
  • [48] Enhanced Long-Term Efficacy of an AAV8-DX88-HSA Vector for Treating Hereditary Angioedema
    Guo, Weimin
    Guo, Yufeng
    Ji, Shuai
    Wen, Shengmei
    Liu, Yiting
    Qu, Guang
    Jiang, Lixin
    MOLECULAR THERAPY, 2024, 32 (04) : 697 - 697
  • [49] Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema
    Duckworth, Edward J.
    Murugesan, Nivetha
    Li, Lily
    Rushbrooke, Louise J.
    Lee, Daniel K.
    De Donatis, Gian Marco
    Maetzel, Andreas
    Yea, Christopher M.
    Hampton, Sally L.
    Feener, Edward P.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1059 - 1070
  • [50] USE OF PURIFIED C1 ESTERASE INHIBITOR IN PATIENTS WITH HEREDITARY ANGIOEDEMA - REPLY
    FRANK, M
    ANESTHESIOLOGY, 1990, 72 (05) : 957 - 957
12345